Franck Charles Marie Grimaud is a businessperson who founded Vivalis SA and who has been the head of 10 different companies. Currently, he is Chairman at Atlanpole Biotherapies, Chief Executive Officer & Director at Atlantic Biotherapies and Director General & Chief Business Officer at Valneva SE, Co-Managing Director at VALNEVA Austria GmbH, Director & Managing Director at Vaccines Holdings Sweden AB, Director & Deputy Chief Executive Officer at Valneva USA, Inc., Director & President at Valneva Canada, Inc. and Director & Deputy Chief Executive Officer at Intercell USA, Inc. (which are all subsidiaries of Valneva SE). Franck Charles Marie Grimaud is also Chief Business Officer for Intercell Austria AG and on the board of 5 other companies.
In the past Mr. Grimaud occupied the position of President & Managing Director at Smol Therapeutics SAS, Chairman at Vivalis Toyama Japan KK and President, CEO & Head-Investor Relations at Vivalis SA.
Mr. Grimaud received an MBA from the University of Ottawa.